Intraday Screener (Update Freq - 1 Min)   Price/Vol, Pivots, New High    SMA / EMA    Over Bought/Sold   Tech Indicators   Candlestick
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Fundamental Analysis of Sanofi India (SANOFI)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

You can now fully customise Watchlist by chosing any combination of your favorites Technical And Fundamental paramenter.

CAGR Growth - Sanofi India Ltd.

CAGR Growth Period Book value Per Share % Operating cash Flow % Earning Per Share % Dividend % EBITDA % Net Income % Revenue % Revenue Per share % Operating Profit % Operating Profit Per Share% EBITDA Per share % Year Range
1 Year 9.50 -14.043 16.87 1088.30 0.000 16.87 11.10 11.10 16.34 16.34 0.000 17-18
3 Year 10.90 20.61 5.82 135.02 0.000 5.82 8.07 8.07 10.83 10.83 0.000 15-18
5 Year 10.70 6.53 7.55 79.72 0.000 7.52 8.88 8.91 9.45 9.48 0.000 13-18
7 Year 10.50 8.97 10.37 58.89 0.000 10.35 11.38 11.41 21.50 21.52 0.000 11-18
10 Year 10.55 12.08 8.66 48.66 0.000 8.65 10.90 10.92 16.09 16.11 0.000 08-18

Balance Sheet of Sanofi India Ltd.

Year Book Value Per Share Capital Work In Progress Net Block Reserves EQ Capital Shareholdings Working Capital Shareholder's Funds Total Debt Current Liablities Total Liablities Cash & Bank Balances Total Assets Capital Employed Current Assets
31_Dec_18 964.78 16.00 738.00 2196.00 23.00 1465.00 2219.00 0.000 765.00 765.00 831.90 2984.00 2219.00 2230.00
31_Dec_17 881.04 30.10 769.00 2003.40 23.00 1227.10 2026.40 0.000 785.90 785.90 729.90 2812.30 2026.40 2013.00
Balance sheet for last 14 Years with 14 Indicators



Cash Flow of Sanofi India Ltd.

Year Cash EPS Cash From Financial Activity Cash From Investing Activity Cash From Operating Activity Net cash Flow
31_Dec_18 162.61 -197.000 -73.000 374.00 104.00
31_Dec_17 189.17 -188.400 -78.700 435.10 168.00
Cash Flow for last 14 Years

Income Statement of Sanofi India Ltd.

Year Corporate Tax Rate Depreciation Expense Total Dividend EBITDA EPS (Earning Per Share) Income Tax Interest Net Income Outstanding Shares Operating Profit Other Income Profit Before Tax Revenue Operating Expense Dividend Total Income Profit Before Depreciation And Tax
31_Dec_18 0.000 103.00 1943.10 0.000 165.65 0.000 1.00 381.00 2.30 625.00 88.00 610.00 2768.00 2143.00 0.000 2856.00 713.00
31_Dec_17 0.366 102.20 163.52 617.90 141.74 188.60 1.10 326.00 2.30 537.20 80.70 514.60 2491.40 1954.20 0.000 2572.10 616.80
Income Statement for last 14 Years with 17 Parameters

Quarterly Income Statement Sanofi India Ltd.

Quarter Corporate Tax Rate Depreciation Expense EBITDA EPS Income Tax Expense Interest Net Income OutStanding Shares Operating Profit Other Income Revenue Total Annual Dividend Total Income Operating Expense Profit Before Depreciation and Tax Face Value
31_Mar_19 0.000 26.00 0.000 40.43 0.000 0.000 93.00 2.30 153.00 23.00 717.00 0.000 740.00 564.00 177.00 10.00
31_Dec_18 0.000 26.00 0.000 34.35 0.000 1.00 79.00 2.30 137.00 20.00 726.00 0.000 746.00 589.00 157.00 10.00
Quarterly Income Statement for last 26 Quarters with 16 Parameters



Risk , price and valuations of Sanofi India Ltd.

Year Market cap Dividend Yield Earning Yield Account Cost of Debit Cost of Equity (CAPM Model) Credit/Default Spread Levered Beta PEG (Price by earning To Growth) PBV (Price To Book Value) PE (Price To earning) PS (Price to Sales - Revenue) Weight to debt (WACC) Weight of equity (WACC) WACC (Weighted cost of Capital) PCFO (Price to cash Flow from Operations) Enterprise value
31_Dec_18 14611.20 0.130 0.030 0.000 0.000 0.120 0.000 2.26 6.58 38.35 5.28 0.000 1.00 0.000 39.07 13779.30
31_Dec_17 10843.10 0.020 0.030 0.000 0.125 0.004 0.190 3.33 5.35 33.26 4.35 0.000 1.00 0.125 24.92 10113.20
Risk Price & Valuation for last 14 Years with 16 Parameters

Profitability And Management Efficiency of Sanofi India Ltd.

Year CROCI (Cash Returns on Capital Invested) Days in Working Capital EBITDA Margin Net Margin Operating cash Flow to Revenue Operating Margin ROCE (Return on Capital Employed) ROE (Return on Equity) Current ratio ROA (return on Assets) ROIC (Return on Invested capital) Asset Turnover CFO To Sales CFO To Turnover(TO) WC to TO Fixed Asset (FA) to TO CFROA (CF to ROA)
31_Dec_18 0.000 190.53 0.000 0.138 0.135 0.226 0.000 0.172 2.92 0.128 0.270 0.928 0.140 3.33 1.89 3.75 0.125
31_Dec_17 0.305 177.31 0.248 0.131 0.175 0.216 0.254 0.161 2.56 0.116 0.250 0.886 0.170 3.41 2.03 3.24 0.155
Profitability & Management Efficiency for last 14 Years with 17 Parameters

Quarterly Profitability /Ratios of Sanofi India Ltd.

Quarter EBITDA Margin IBT Margin Net Margin Operating Margin) Market Capitalization Dividend Yield Levered Beta Dividend Payout Retention Ratio
31_Mar_19 0.000 0.130 0.000 0.213 13420.80 0.000 0.000 0.000 0.000
31_Dec_18 0.000 0.109 0.000 0.189 14611.20 0.000 0.000 0.000 0.000
Profitability & Management Efficiency for last 26 Quarters with 9 Parameters


Solvency & Fundamentals of Sanofi India Ltd.

Year Capitalization Ratio Interest Coverage Long Term Debt to EBITDA Long Term Debt to Equity (Net Worth) Solvency Ratio Dividend Payout Retention Ratio Times Interest Earned Cash Ratio Accruals CFO to Debt Debt To Assets Debt To Capital Assets to Shareholder Equity Dividend Cover
31_Dec_18 0.000 0.000 0.000 0.000 0.000 5.10 -4.100 0.000 1.09 7.00 0.000 0.000 0.000 1.34 0.090
31_Dec_17 0.000 468.82 0.000 0.000 0.000 0.502 0.500 0.000 0.930 -109.100 0.000 0.000 0.000 1.39 0.870
Solvency & Fundamentals for last 14 Years with 15 Parameters

Financial Data From D'Market


(All analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.